메뉴 건너뛰기




Volumn 11, Issue 1, 2010, Pages 247-252

Stability of 5-fluoro-2′-deoxycytidine and tetrahydrouridine in combination

Author keywords

Degradation mechanism; FdCyd; NSC 112907; NSC 48006; THU

Indexed keywords

FLUCYTOSINE DEOXYRIBOSIDE; NSC 48006; TETRAHYDROURIDINE; UNCLASSIFIED DRUG;

EID: 77950917644     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9383-2     Document Type: Article
Times cited : (14)

References (5)
  • 1
    • 33846260563 scopus 로고    scopus 로고
    • Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine in mice
    • DOI 10.1158/1078-0432.CCR-06-1250
    • JH Beumer JL Eiseman RA Parise E Joseph JL Holleran JM Covey, et al. 2006 Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine in mice Clin Cancer Res 12 7483 7491 10.1158/1078-0432.CCR-06-1250 1:CAS:528:DC%2BD28XhtlCrtrzF 17138702 (Pubitemid 46095424)
    • (2006) Clinical Cancer Research , vol.12 , Issue.24 , pp. 7483-7491
    • Beumer, J.H.1    Eiseman, J.L.2    Parise, R.A.3    Joseph, E.4    Holleran, J.L.5    Covey, J.M.6    Egorin, M.J.7
  • 2
    • 43749124047 scopus 로고    scopus 로고
    • Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2′- deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU)
    • DOI 10.1007/s00280-007-0603-8
    • JH Beumer RA Parise EM Newman JH Doroshow TW Synold H-J Lenz, et al. 2008 Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2′- deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU) Cancer Chemother Pharmacol 62 363 368 10.1007/s00280-007-0603-8 1:CAS:528:DC%2BD1cXlvVWitbk%3D 17899082 (Pubitemid 351692084)
    • (2008) Cancer Chemotherapy and Pharmacology , vol.62 , Issue.2 , pp. 363-368
    • Beumer, J.H.1    Parise, R.A.2    Newman, E.M.3    Doroshow, J.H.4    Synold, T.W.5    Lenz, H.-J.6    Egorin, M.J.7
  • 3
    • 0017927837 scopus 로고
    • Analysis of cytidine deaminase and tetrahydrouridine interaction by use of ligand techniques
    • DOI 10.1016/0006-2952(78)90256-3
    • RG Stoller CE Myers BA Chabner 1978 Analysis of cytidine deaminase and tetrahydrouridine interaction by use of ligand techniques Biochem Pharmacol 27 53 59 10.1016/0006-2952(78)90256-3 1:CAS:528:DyaE1cXhtlams70%3D 619907 (Pubitemid 8239568)
    • (1978) Biochemical Pharmacology , vol.27 , Issue.1 , pp. 53-59
    • Stoller, R.G.1    Myers, C.E.2    Chabner, B.A.3
  • 4
    • 0023269818 scopus 로고
    • Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma
    • DA Boothman TV Briggle S Greer 1987 Tumor-selective metabolism of 5-fluoro-2′-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma Cancer Res 47 2354 2362 1:CAS:528:DyaL2sXksFWnu7w%3D 2952263 (Pubitemid 17099196)
    • (1987) Cancer Research , vol.47 , Issue.9 , pp. 2354-2362
    • Boothman, D.A.1    Briggle, T.V.2    Greer, S.3
  • 5
    • 0141619288 scopus 로고    scopus 로고
    • Epimer interconversion, isomerization, and hydrolysis of tetrahydrouridine: Implications for cytidine deaminase inhibition
    • DOI 10.1002/jps.10447
    • T Xiang R Niemi P Bummer BD Anderson 2003 Epimer interconversion, isomerization, and hydrolysis of tetrahydrouridine: implications for cytidine deaminase inhibition J Pharma Sci 92 2027 2039 10.1002/jps.10447 1:CAS:528:DC%2BD3sXnvFOms7o%3D (Pubitemid 37175633)
    • (2003) Journal of Pharmaceutical Sciences , vol.92 , Issue.10 , pp. 2027-2039
    • Xiang, T.-X.1    Niemi, R.2    Bummer, P.3    Anderson, B.D.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.